Drug level in Swiss CD1 mouse plasma treated with 5-(3-(Pyridin-3-yl)-5-(trifluoromethyl)phenyl)-N-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2...

Basic Information

ID: ALA4018983

Type: ADME

Description: Drug level in Swiss CD1 mouse plasma treated with 5-(3-(Pyridin-3-yl)-5-(trifluoromethyl)phenyl)-N-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine at 500 mg/kg, po by HPLC analysis

Format: BAO_0000218

Organism: Mus musculus

Strain: Swiss CD1

Tissue: Plasma

Target:  Plasma(ALA613589)

Document:  ALA4017499

Drug level in Swiss CD1 mouse plasma treated with 5-(3-(Pyridin-3-yl)-5-(trifluoromethyl)phenyl)-N-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine at 500 mg/kg, po by HPLC analysis: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
483.494.834.83
267.213.473.47